Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes
The British Journal of Psychiatry · 2026
DOI: 10.1192/bjp.2025.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, 2026. Verfasst von Megan Cowman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroimaging, Cognition & Genomics (NICOG), School of Psychology, University of Galway, Galway, Ireland. Hauptthemen laut MEDLINE: Psychotic Disorders, Cognitive Dysfunction, Psychosocial Functioning. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
While cognitive impairment is a core feature of psychosis, significant heterogeneity in cognitive and clinical outcomes is observed.
Aims
The aim of this study was to identify cognitive and clinical subgroups in first-episode psychosis (FEP) and determine if these profiles were linked to functional outcomes over time.
Method
A total of 323 individuals with FEP were included. Two-step hierarchical and k -means cluster analyses were performed using baseline cognitive and clinical variables. General linear mixed models were used to investigate whether baseline cognitive and clinical clusters were associated with functioning at follow-up time points (6–9, 12 and 15 months).
Results
Three distinct cognitive clusters were identified: a cognitively intact group ( N = 59), a moderately impaired group ( N = 77) and a more severely impaired group ( N = 122). Three distinct clinical clusters were identified: a subgroup characterised by predominant mood symptoms ( N = 76), a subgroup characterised by predominant negative symptoms ( N = 19) and a subgroup characterised by overall mild symptom severity ( N = 94). The subgroup with more severely impaired cognition also had more severe negative symptoms at baseline. Cognitive clusters were significantly associated with later social and occupational function, and associated with changes over time. Clinical clusters were associated with later social functioning but not occupational functioning, and were not associated with changes over time.
Conclusions
Baseline cognitive impairments are predictive of both later social and occupational function and change over time. This suggests that cognitive profiles offer valuable information in terms of prognosis and treatment needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Neuroimaging, Cognition & Genomics (NICOG), School of Psychology, University of Galway, Galway, Ireland.
- Department of Clinical Psychology and Psychological Therapies, Norwich Medical School, University of East Anglia, Norwich, UK.
- Institute for Mental Health, University of Birmingham, Birmingham, UK.
- RISE Early Intervention in Psychosis Service, South Lee Mental Health Service, Cork, Ireland.
- Psychology Department, University of Sussex, Brighton, UK.
- Warwick Medical School, University of Warwick, Coventry, UK.
ORCID-Profile: Siân Lowri Griffiths, Gary Donohoe
Zitieren
APA
Cowman, M., Hodgekins, J., Griffiths, S. L., Frawley, E., O'Connor, K., Fowler, D., Birchwood, M., & Donohoe, G. (2026). Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2025.3
Vancouver
Cowman M, Hodgekins J, Griffiths SL, Frawley E, O'Connor K, Fowler D, et al. Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes. The British Journal of Psychiatry. 2026. doi:10.1192/bjp.2025.3
BibTeX
@article{Cowman2026,
author = {Cowman, Megan and Hodgekins, Jo and Griffiths, Siân Lowri and Frawley, Emma and O'Connor, Karen and Fowler, David and Birchwood, Max and Donohoe, Gary},
title = {Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes},
journal = {The British Journal of Psychiatry},
year = {2026},
doi = {10.1192/bjp.2025.3}
}
EUVIMED